<!doctype html><html class=no-js lang=en><head><meta charset=UTF-8><meta name=viewport content="width=device-width,initial-scale=1"><title>ç§‘ç ”æ—¥æŠ¥ 2026-01-18 - ç”Ÿä¿¡æ™®æ‹‰æ–¯</title>
<script>(function(e,t){e[t]=e[t].replace("no-js","js")})(document.documentElement,"className")</script><meta name=description content><meta property="og:url" content="https://ixxmu.github.io/posts/dailyreports/2026-01-18/"><meta property="og:site_name" content="ç”Ÿä¿¡æ™®æ‹‰æ–¯"><meta property="og:title" content="ç§‘ç ”æ—¥æŠ¥ 2026-01-18"><meta property="og:description" content="ğŸ“… Daily Report - 2026-01-18 ä»Šæ—¥ç­›é€‰å‡º 42 æ¡å†…å®¹ï¼Œæ¥è‡ª 2 ä¸ªæ¥æº"><meta property="og:locale" content="zh_cn"><meta property="og:type" content="article"><meta property="article:section" content="posts"><meta property="article:published_time" content="2026-01-18T00:00:00+00:00"><meta property="article:modified_time" content="2026-01-18T00:00:00+00:00"><meta property="article:tag" content="Research"><meta property="article:tag" content="Daily"><meta property="article:tag" content="Week032026"><meta itemprop=name content="ç§‘ç ”æ—¥æŠ¥ 2026-01-18"><meta itemprop=description content="ğŸ“… Daily Report - 2026-01-18 ä»Šæ—¥ç­›é€‰å‡º 42 æ¡å†…å®¹ï¼Œæ¥è‡ª 2 ä¸ªæ¥æº"><meta itemprop=datePublished content="2026-01-18T00:00:00+00:00"><meta itemprop=dateModified content="2026-01-18T00:00:00+00:00"><meta itemprop=wordCount content="2201"><meta itemprop=keywords content="Research,Daily,Week032026"><meta name=twitter:card content="summary"><meta name=twitter:title content="ç§‘ç ”æ—¥æŠ¥ 2026-01-18"><meta name=twitter:description content="ğŸ“… Daily Report - 2026-01-18 ä»Šæ—¥ç­›é€‰å‡º 42 æ¡å†…å®¹ï¼Œæ¥è‡ª 2 ä¸ªæ¥æº"><link rel=preconnect href=https://fonts.gstatic.com crossorigin><link rel=dns-prefetch href=//fonts.googleapis.com><link rel=dns-prefetch href=//fonts.gstatic.com><link rel=stylesheet href="https://fonts.googleapis.com/css?family=Open+Sans:400,400i,700"><link rel=stylesheet href=../../../css/style.css><link rel=stylesheet href=../../../css/custom.css><link rel="shortcut icon" href=../../../favicon.ico></head><body class=body><div class="container container--outer"><header class=header><div class="container header__container"><div class=logo><a class=logo__link href=../../../ title=ç”Ÿä¿¡æ™®æ‹‰æ–¯ rel=home><div class="logo__item logo__text"><div class=logo__title>ç”Ÿä¿¡æ™®æ‹‰æ–¯</div><div class=logo__tagline>è¿‘åå¹´æœ€å€¼å¾—ä¸Šæ‰‹çš„ç”Ÿç‰©åŒ»å­¦ç”Ÿä¿¡ä»£ç </div></div></a></div><nav class=menu><button class=menu__btn aria-haspopup=true aria-expanded=false tabindex=0>
<span class=menu__btn-title tabindex=-1>Menu</span></button><ul class=menu__list><li class=menu__item><a class=menu__link href=../../../posts/><span class=menu__text>æ–‡ç« </span></a></li><li class=menu__item><a class=menu__link href=../../../tags/><span class=menu__text>æ ‡ç­¾</span></a></li><li class=menu__item><a class=menu__link href=../../../about/><span class=menu__text>å…³äº</span></a></li></ul></nav></div></header><div class="wrapper flex"><div class=primary><main class=main role=main><article class=post><header class=post__header><meta name=referrer content="never"><h1 class=post__title>ç§‘ç ”æ—¥æŠ¥ 2026-01-18</h1><div class="post__meta meta"><div class="meta__item-datetime meta__item"><svg class="meta__icon icon icon-time" width="16" height="14" viewBox="0 0 30 28"><path d="M15 0a14 14 0 110 28 1 1 0 010-28m0 3a3 3 0 100 22 3 3 0 000-22m1 4h-2v8.4l6.8 4.4L22 18l-6-3.8z"/></svg><time class=meta__text datetime=2026-01-18T00:00:00Z>2026-01-18</time></div><div class="meta__item-categories meta__item"><svg class="meta__icon icon icon-category" width="16" height="16" viewBox="0 0 16 16"><path d="m7 2 1 2h8v11H0V2z"/></svg><span class=meta__text><a class=meta__link href=../../../categories/dailyreport/ rel=category>DailyReport</a></span></div><div class="meta__item-author meta__item"><svg class="meta__icon icon icon-author" width="16" height="16" viewBox="0 0 16 16"><path d="M8 1c2 0 3.5 2 3.5 4.5S10 9 10 9c3 1 4 2 4 6H2c0-4 1-5 4-6 0 0-1.5-1-1.5-3.5S6 1 8 1"/></svg><span class=meta__text>Bloger</span></div></div></header><div class="post__toc toc"><div class=toc__title>Page content</div><div class=toc__menu><nav id=TableOfContents><ul><li><a href=#-ä»Šæ—¥aiæ™ºèƒ½æ€»ç»“>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</a><ul><li><a href=#-æ•°æ®å‰æ²¿>ğŸ§¬ æ•°æ®å‰æ²¿</a></li><li><a href=#-åšå®¢æ›´æ–°>ğŸ§ª åšå®¢æ›´æ–°</a></li></ul></li><li><a href=#-åˆ†ç±»æµè§ˆ>ğŸ“š åˆ†ç±»æµè§ˆ</a><ul><li></li></ul></li><li><a href=#-å…³é”®è¯ç»Ÿè®¡>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</a></li><li><a href=#-æ›´å¤šå†…å®¹>ğŸ“ æ›´å¤šå†…å®¹</a></li></ul></nav></div></div><div class="content post__content clearfix"><h1 id=-daily-report---2026-01-18>ğŸ“… Daily Report - 2026-01-18</h1><blockquote><p>ä»Šæ—¥ç­›é€‰å‡º <strong>42</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>2</strong> ä¸ªæ¥æº</p></blockquote><div class=powered-by-top>Powered by <a href=https://kyplus.de>ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href=https://claude.ai>Claude</a></div><hr><h2 id=-ä»Šæ—¥aiæ™ºèƒ½æ€»ç»“>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2><h3 id=-æ•°æ®å‰æ²¿>ğŸ§¬ æ•°æ®å‰æ²¿</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š</p></blockquote><ul><li><strong>è‚¿ç˜¤å¾®ç¯å¢ƒé‡å¡‘æœºåˆ¶æ­ç¤º</strong>ï¼šå¤šé¡¹ç ”ç©¶èšç„¦æŸ“è‰²ä½“ä¸ç¨³å®šæ€§ï¼ˆCINï¼‰å¦‚ä½•é€šè¿‡cGAS-è¶‹åŒ–å› å­-é«“ç³»ç»†èƒè½´é‡å¡‘é£Ÿç®¡è…ºç™Œå¾®ç¯å¢ƒï¼Œä»¥åŠClaudinsä¸LILRBå…ç–«æŠ‘åˆ¶å—ä½“çš„ç›¸äº’ä½œç”¨ä¿ƒè¿›é«“ç³»ç»†èƒå…ç–«æŠ‘åˆ¶ã€‚</li></ul><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li><strong>è‚¿ç˜¤è½¬ç§»ä¸å…ç–«è°ƒæ§</strong>ï¼šç ”ç©¶è‚¿ç˜¤ç»†èƒç°‡å¢å¼ºè½¬ç§»èƒ½åŠ›ï¼ˆè°ƒæ§H3K36ç»„è›‹ç™½å»ç”²åŸºåŒ–é…¶KDM2Aï¼‰ï¼ŒHMGB2ä½œä¸ºåŒé‡å…ç–«è°ƒèŠ‚å‰‚åœ¨è‚ç»†èƒç™Œä¸­å¢å¼ºCD8+ Tç»†èƒåŠŸèƒ½å¹¶æŠ‘åˆ¶è‚¿ç˜¤ç”Ÿé•¿ã€‚</li><li><strong>Tç»†èƒåŠŸèƒ½ä¸åˆ†åŒ–</strong>ï¼šæ¢ç´¢Dnmt3aä¾èµ–çš„DNAå»ç”²åŸºåŒ–å¦‚ä½•ç»´æŒè®°å¿†Th1å’ŒTfhç»†èƒçš„åŠŸèƒ½ï¼Œä»¥åŠPD-1ç¼ºå¤±çš„CD8+ Tç»†èƒåœ¨æ…¢æ€§åˆºæ¿€ä¸‹çš„é€‚åº”æ€§æœºåˆ¶ã€‚</li><li><strong>è‚¿ç˜¤è€è¯æ€§æœºåˆ¶</strong>ï¼šæ­ç¤ºAURKA/PHB2ä¿¡å·é€šè·¯é©±åŠ¨KRAS G12Cçªå˜éå°ç»†èƒè‚ºç™Œå¯¹KRAS G12CæŠ‘åˆ¶å‰‚è·å¾—æ€§è€è¯ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li><strong>å•ç»†èƒæµ‹åºåº”ç”¨</strong>ï¼šå¹¿æ³›åº”ç”¨äºèƒ°è…ºå¯¼ç®¡è…ºç™Œï¼ˆPDAï¼‰ç»†èƒç³»ç ”ç©¶ï¼ŒåŒ…æ‹¬è¯ç‰©å¤„ç†å‰åã€ä»¥åŠç”¨äºè°±ç³»è¿½è¸ªã€‚</li><li><strong>ç»„è›‹ç™½ä¿®é¥°ä¸åŸºå› ç»„ç»“åˆåˆ†æ</strong>ï¼šChIP-Seqå’ŒATAC-seqç­‰æŠ€æœ¯ç”¨äºè§£æç»„è›‹ç™½ä¿®é¥°å’ŒæŸ“è‰²è´¨å¯åŠæ€§å¯¹åŸºå› è¡¨è¾¾åŠç»†èƒåŠŸèƒ½çš„å½±å“ã€‚</li></ul><h3 id=-åšå®¢æ›´æ–°>ğŸ§ª åšå®¢æ›´æ–°</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
æ–°å‹AIæ¡†æ¶CellAtriaé¦–æ¬¡å®ç°å•ç»†èƒRNAæµ‹åºæ•°æ®çš„è‡ªåŠ¨åŒ–ã€æ ‡å‡†åŒ–åˆ†æï¼Œå¤§å¹…æå‡å…¬å…±æ•°æ®é›†çš„å¯åŠæ€§ï¼›åŒæ—¶å‘ç°ç»´ç”Ÿç´ Aä»£è°¢äº§ç‰©èƒ½æŠ‘åˆ¶å…ç–«ç³»ç»Ÿï¼ŒåŠ©è‚¿ç˜¤é€ƒé¿å…ç–«æ”»å‡»ï¼Œå¹¶å·²å¼€å‘å‡ºé¶å‘è¯ç‰©ã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li>è‡ªåŠ¨åŒ–å•ç»†èƒRNAæµ‹åºæ•°æ®åˆ†æä¸æ ‡å‡†åŒ–</li><li>ç»´ç”Ÿç´ Aä»£è°¢äº§ç‰©å¯¹è‚¿ç˜¤å…ç–«é€ƒé€¸çš„å½±å“åŠå…¶å¹²é¢„</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li>åŸºäºAgentic AIçš„å•ç»†èƒæ•°æ®å¤„ç†æ¡†æ¶</li><li>é¶å‘ç»´ç”Ÿç´ Aä»£è°¢é€šè·¯ä»¥å¢å¼ºæŠ—è‚¿ç˜¤å…ç–«çš„è¯ç‰©å¼€å‘</li></ul><hr><h2 id=-åˆ†ç±»æµè§ˆ>ğŸ“š åˆ†ç±»æµè§ˆ</h2><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ§¬ æ•°æ®å‰æ²¿ (40æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å‰10æ¡>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4><p><strong>1.</strong> â­ <strong>GSE316752 è‚¿ç˜¤ç»†èƒèšé›†é€šè¿‡è°ƒèŠ‚ H3K36 ç»„è›‹ç™½å»ç”²åŸºåŒ–é…¶ KDM2A å¢å¼ºè½¬ç§»èƒ½åŠ› [ChIP-Seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€ChIP-seqã€histoneã€clustering</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Carolyn Kravitz ; Kiran D Patel ; Emily Wingrove ; Dejian Zhao ; Tang Tang ; Sampada Chande ; Yuchen Huo ; Thomas F Westbrook ; Qin Yan ; Don X NguyenSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Homo sapiensDisseminated tumor cells can form clusters via cell-cell adhesion, which increases their capacity to initiate metastasis. Metastatic clusters are characterized by distinct changes in transcription, suggesting that epigenetic mechanisms underlie their unique phenotypic state. By performingfunctional epigenomic studies in models of non-small-cell lung cancer, we identified the histone H3 lysine 36 (H3K36) demethylase KDM2A as being differentially required for the fitness of metastatic cell clusters. This contextual dependency on KDM2A is predicated by tumor cell-cell aggregation, which specifically induces KDM2A binding to CpG island enriched promoters. At these defined genomic loci, KDM2A maintains H3K36 monomethylation, which preferentially correlates with transcriptional activation. KDM2A directly targets oxidative phosphorylation genes and KDM2A activity is required for optimal mitochondrial respiration and apical cell junction integrity in cell clusters. Consequently, suppressing KDM2A reduces metastatic seeding and colonization in multiple organs, including in the brain. These findings reveal a chromatin regulatory mechanism by which homotypic cell communication instructs the epigenome of disseminated tumor cells to potentiate their metastatic competence.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316752">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> â­ <strong>GSE316191 é¶å‘ HMGB2 å¯ä½œä¸ºåŒé‡å…ç–«è°ƒèŠ‚å‰‚ï¼Œé€šè¿‡å¢å¼º CD8+ T ç»†èƒåŠŸèƒ½å’ŒæŠ‘åˆ¶è‚ç»†èƒç™Œçš„è‚¿ç˜¤ç”Ÿé•¿å‘æŒ¥ä½œç”¨ [ATAC-seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€carcinomaã€T cellã€ATAC-seq</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Weifeng Qu ; Guiqi Zhu ; Yinghong ShiSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Mus musculusT cell exhaustion is a critical obstacle for durable treatment response in hepatocellular carcinoma (HCC). Developing drugs that control tumor growth and simultaneously bolster immune function is of great significance. The transcriptional regulator high mobility group box 2 (HMGB2) has emerged as a risk factor in prognosis of HCC. However, the role of HMGB2 in HCC tumor microenvironment (TME) is poorly understood. Here, we discovered HMGB2+ CD8+ T cells as being associated with T cell exhaustion and resistance to anti-PD-1 treatment through single-cell RNA sequencing of human and murine HCC tissues. Mechanistically, HMGB2 impaired the mitochondrial oxidative phosphorylation in CD8+ T cells by increasing the ubiquitination of NRF2, thus reduced the antitumor effector function. In tumor cells, HMGB2 inactivated the interferon-Î³ (IFN-Î³) response through TRIM24/STAT1 pathway, inhibiting susceptibility and recruitment to effector T cells. Tannic acid, a specific inhibitor of HMGB2, synergized with PD-1 antibody to attenuate tumor growth and reverse T cell exhaustion. Collectively, this study revealed that HMGB2, a T cell exhaustion associated molecule, contributed to tumor immune escape by dual action on CD8+ T cells and tumor cells. These data also provided translational insight into synergistic treatment strategies.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316191">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> â­ <strong>GSE315942 æŸ“è‰²ä½“ä¸ç¨³å®šæ€§é€šè¿‡ cGASâ€“è¶‹åŒ–å› å­â€“é«“ç³»è½´å¡‘é€ é£Ÿç®¡è…ºç™Œçš„è‚¿ç˜¤å¾®ç¯å¢ƒ [RNA-seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€tumor microenvironmentã€chemokineã€RNA-seq</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Bruno Beernaert ; Eileen E ParkesSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensChromosomal instability (CIN), a pervasive feature of esophageal adenocarcinoma (EAC), drives tumor aggressiveness and metastasis. CIN stimulates the cGASâ€“STING pathway, typically linked to anti-tumor immunity. However, despite the high CIN burden in EAC, the cGASâ€“STING pathway remains largely intact. To address this paradox, we interrogated multiple esophageal cancer models, discovering myeloid-attracting chemokines â€“ with CXCL8 as a prominent hit â€“ as conserved CIN-driven targets in EAC. Using multiplexed immunofluorescence microscopy, we quantified ongoing CIN in human EAC tumors by measuring cGAS-positive micronuclei, validated by whole-genome sequencing. Coupling in situ CIN detection with single-nucleus RNA sequencing and multiplex immunophenotyping of human EAC, we link CIN to tumor-intrinsic innate immune activation, CXCL8 expression, and myeloid cell-mediated immunosuppression. In EAC patients, CIN-high, myeloid-dominated tumors correlate with poor outcomes and aberrant cGASâ€“STING signaling. These insights explain the counterintuitive maintenance of cGASâ€“STING and highlight disruption of the CINâ€“cGASâ€“inflammation axis as a potential therapeutic strategy in EAC.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315942">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>4.</strong> â­ <strong>GSE316655 Claudins ä¸ LILRB å…ç–«æŠ‘åˆ¶å—ä½“ç›¸äº’ä½œç”¨ï¼Œä¿ƒè¿›ç™Œç—‡ä¸­çš„é«“ç³»å…ç–«æŠ‘åˆ¶</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€immuneã€regex:immuno(logy|therapy|suppression)</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Xiaoye Liu ; Alec Zhang ; Kenian ChenSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensThe mechanisms underlying tumor cell-myeloid cell interactions within the tumor microenvironment (TME) remain unclear, and predictive biomarkers for patient response to myeloid checkpoint blockade are lacking. This study identified specific binding between tight-junction claudins (CLDNs) and leukocyte immunoglobulin-like receptor subfamily B members LILRB2 and LILRB5. In multiple human cancer cohorts, the spatial proximity of LILRB2âº macrophages to CLDN-expressing cancer cells correlated with clinical outcomes, nominating this spatial relationship as a potential biomarker. In syngeneic LILRB2-transgenic and humanized mouse models, CLDN18.2â€“LILRB2 interaction triggered bidirectional signaling, enhanced the immunosuppressive activity of myeloid cells, and accelerated tumor progression. These effects were reversed by LILRB2 blockade. Mechanistically, the CLDN-LILRB2 axis sustained immunosuppression by regulating NF-ÎºB and STAT signaling pathways. Our findings reveal a novel tight junction protein-mediated mechanism of myeloid cell regulation in the TME, offering a rationale for targeting this pathway in cancer therapy.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316655">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>5.</strong> â­ <strong>GSE316127 æŸ“è‰²ä½“ä¸ç¨³å®šæ€§é€šè¿‡ cGAS-è¶‹åŒ–å› å­-é«“ç³»è½´å¡‘é€ é£Ÿç®¡è…ºç™Œçš„è‚¿ç˜¤å¾®ç¯å¢ƒ</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€tumor microenvironmentã€chemokine</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Bruno Beernaert ; Eileen E ParkesSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensChromosomal instability (CIN), a pervasive feature of esophageal adenocarcinoma (EAC), drives tumor aggressiveness and metastasis. CIN stimulates the cGASâ€“STING pathway, typically linked to anti-tumor immunity. However, despite the high CIN burden in EAC, the cGASâ€“STING pathway remains largely intact. To address this paradox, we interrogated multiple esophageal cancer models, discovering myeloid-attracting chemokines â€“ with CXCL8 as a prominent hit â€“ as conserved CIN-driven targets in EAC. Using multiplexed immunofluorescence microscopy, we quantified ongoing CIN in human EAC tumors by measuring cGAS-positive micronuclei, validated by whole-genome sequencing. Coupling in situ CIN detection with single-nucleus RNA sequencing and multiplex immunophenotyping of human EAC, we link CIN to tumor-intrinsic innate immune activation, CXCL8 expression, and myeloid cell-mediated immunosuppression. In EAC patients, CIN-high, myeloid-dominated tumors correlate with poor outcomes and aberrant cGASâ€“STING signaling. These insights explain the counterintuitive maintenance of cGASâ€“STING and highlight disruption of the CINâ€“cGASâ€“inflammation axis as a potential therapeutic strategy in EAC.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316127">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>6.</strong> â­ <strong>GSE316062 æŸ“è‰²ä½“ä¸ç¨³å®šæ€§é€šè¿‡ cGASâ€“è¶‹åŒ–å› å­â€“é«“ç³»è½´å¡‘é€ é£Ÿç®¡è…ºç™Œçš„è‚¿ç˜¤å¾®ç¯å¢ƒ [snRNA-Seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€tumor microenvironmentã€chemokine</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Bruno Beernaert ; Eileen E ParkesSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensChromosomal instability (CIN), a pervasive feature of esophageal adenocarcinoma (EAC), drives tumor aggressiveness and metastasis. CIN stimulates the cGASâ€“STING pathway, typically linked to anti-tumor immunity. However, despite the high CIN burden in EAC, the cGASâ€“STING pathway remains largely intact. To address this paradox, we interrogated multiple esophageal cancer models, discovering myeloid-attracting chemokines â€“ with CXCL8 as a prominent hit â€“ as conserved CIN-driven targets in EAC. Using multiplexed immunofluorescence microscopy, we quantified ongoing CIN in human EAC tumors by measuring cGAS-positive micronuclei, validated by whole-genome sequencing. Coupling in situ CIN detection with single-nucleus RNA sequencing and multiplex immunophenotyping of human EAC, we link CIN to tumor-intrinsic innate immune activation, CXCL8 expression, and myeloid cell-mediated immunosuppression. In EAC patients, CIN-high, myeloid-dominated tumors correlate with poor outcomes and aberrant cGASâ€“STING signaling. These insights explain the counterintuitive maintenance of cGASâ€“STING and highlight disruption of the CINâ€“cGASâ€“inflammation axis as a potential therapeutic strategy in EAC.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316062">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>7.</strong> <strong>GSE316732 é›·å¸•éœ‰ç´ é€†è½¬è‚è„å¯¹é¥®é£Ÿè¯±å¯¼çš„ä»£è°¢åº”æ¿€çš„ååº”ï¼Œè¿™ç§ååº”ä¼šéšç€å¹´é¾„çš„å¢é•¿è€ŒåŠ å‰§ã€‚</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šagingã€metabolic</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Aaron P. Havas ; Adarsh Rajesh ; Xue Lei ; Peter D. AdamsSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusAging is associated with increased susceptibility to metabolic stress and chronic liver disease, yet the interactions between age and metabolic stressors and the potential for ameliorating interventions remain incompletely understood. Here, we examined the hepatic response of young (7-month-old) and old (25-month-old) C57BL/6 male mice to a 9-week high-fat diet (HFD) and assessed whether rapamycin, a well-established pro-longevity intervention, could mitigate age-exacerbated effects. While both age groups developed metabolic-associated steatohepatitis (MASH), older mice displayed more severe hepatic steatosis, inflammation, and transcriptional dysregulation. Transcriptomic profiling of whole livers and purified hepatocytes revealed that aging amplifies HFD-induced inflammatory and metabolic gene expression changes, including activation of immune pathways and suppression of metabolic pathways. Notably, treatment of aging mice with rapamycin reversed the majority of HFD-driven transcriptional alterations, including upregulation of pro-inflammatory regulators such as Stat1, and dysregulation of metabolic gene networks. Rapamycin also reduced hepatosteatosis, total body weight, and a tumorigenic transcriptomic signature associated with hepatocellular carcinoma risk. These findings demonstrate that aging intensifies hepatic sensitivity to dietary metabolic stress and identify rapamycin as a promising therapeutic to counteract age-related liver dysfunction and metabolic dysfunction-associated steatotic liver disease (MASLD) progression.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316732">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>8.</strong> <strong>GSE291910 Dnmt3a ä¾èµ–çš„ä»å¤´ DNA ç”²åŸºåŒ–å¢å¼ºè°±ç³»å®šå‘å¹¶ä¿æŒè®°å¿† Th1 å’Œ Tfh ç»†èƒçš„åŠŸèƒ½ [RNA-seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šRNA-seqã€methylation</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Scott Hale ; Bryant PerkinsSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusFollowing acute viral infection, naÃ¯ve CD4+ T cells differentiate into T follicular helper (Tfh) and T helper 1 (Th1) cells that generate long-lived memory cells. However, it is unclear how memory Tfh and Th1 cells maintain their lineage commitment. We demonstrate that Tfh and Th1 lineages acquire distinct Dnmt3a-dependent de novo DNA methylation programs that are preserved into memory. Dnmt3a deletion impairs lineage commitment and functionality of memory Th1 and Tfh cells, resulting in aberrant Runx1 upregulation that represses germinal center Tfh cell differentiation. In contrast, transient pharmacological DNA methyltransferase inhibition during priming impairs repression of Tfh-associated genes while properly silencing Runx1, and results in enhanced Tfh cell functionality in primary and secondary responses to viral infections. Together, these findings demonstrate that Dnmt3a-mediated epigenetic programing is required to enforce T helper lineage commitment and preserve Tfh and Th1-specific functions during the recall response to infection, and reveal novel strategies to improve long-lived adaptive immunity against infectious diseases.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291910">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>9.</strong> <strong>GSE270117 7ç§PDAç»†èƒç³»çš„å•ç»†èƒRNAæµ‹åº</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šsequencingã€single-cell</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Pasquale Laise ; Mikko Turunen ; Alvaro C Garcia ; Lorenzo Tomassoni ; H C Maurer ; Ela Elyada ; Bernhard Schmierer ; Jeremy Worley ; Jordan Kesner ; Xiangtian Tan ; Ester C Fernandez ; Xue Yuanqing ; Chen Yining ; Kelly Wong ; Urszula N Wasko ; Somnath Tagore ; Alexander L Wang ; Sabrina Ge ; Alina C Iuga ; Aaron Griffin ; Winston Wong ; Gulam A Manji ; Mariano J Alvarez ; Faiyaz Notta ; David A Tuveson ; Kenneth P Olive ; Andrea CalifanoSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensWe performed Single-Cell RNA Sequencing of 7 PDA Cell Lines to characterize and quantify PDA subtypes populations</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE270117">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>10.</strong> <strong>GSE159921 æ··åˆè½¬å½•å› å­è¿‡è¡¨è¾¾åˆ†æï¼ˆå•ç»†èƒRNAæµ‹åºï¼‰</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šRNAseqã€single-cell</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Pasquale Laise ; Mikko Turunen ; Alvaro C Garcia ; Lorenzo Tomassoni ; H C Maurer ; Ela Elyada ; Bernhard Schmierer ; Jeremy Worley ; Jordan Kesner ; Xiangtian Tan ; Ester C Fernandez ; Sue Yuanqing ; Chen Yining ; Kelly Wong ; Urszula N Wasko ; Somnath Tagore ; Alexander L Wang ; Sabrina Ge ; Alina C Iuga ; Aaron Griffin ; Winston Wong ; Gulam A Manji ; Mariano J Alvarez ; Faiyaz Notta ; David A Tuveson ; Kenneth P Olive ; Andrea CalifanoSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensThe aim of this study is to investigate the effect of the combinatorial overexpression of the top GLS MRs in a MOS cell line (at single-cell level).</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE159921">æŸ¥çœ‹åŸæ–‡</a></li></ul><blockquote><p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 30 æ¡å†…å®¹ï¼Œè¯¦è§ <a href=#%E6%9B%B4%E5%A4%9A-%E6%95%B0%E6%8D%AE%E5%89%8D%E6%B2%BF>æ–‡æœ«</a></p></blockquote></div></details><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ§ª åšå®¢æ›´æ–° (2æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å…¨éƒ¨2æ¡>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨2æ¡ï¼‰</h4><p><strong>1.</strong> <strong>ç”¨äºå•ç»†èƒRNAæµ‹åºæ•°æ®åˆ†ææ‘„å–å’Œæ ‡å‡†åŒ–çš„æ™ºèƒ½ä½“AIæ¡†æ¶</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šRNA-seqã€single-cell</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šCellAtria uses AI to automate data ingestion and RNA sequencing analysis, making reuse of public single-cell datasets faster, standardized, and accessible without advanced computational skills&mldr;</li><li>ğŸ”— <a href=https://www.rna-seqblog.com/an-agentic-ai-framework-for-ingestion-and-standardization-of-single-cell-rna-seq-data-analysis/>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> <strong>ç»´ç”Ÿç´ Aå¯èƒ½æœ‰åŠ©äºç™Œç»†èƒèº²é¿å…ç–«ç³»ç»Ÿçš„æ”»å‡»ã€‚</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€immune</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šA vitamin A byproduct has been found to quietly disarm the immune system, allowing tumors to evade attack and weakening cancer vaccines. Scientists have now developed a drug that shuts down this pathway, dramatically boosting immune responses and slowing cancer growth in preclinical studies.</li><li>ğŸ”— <a href=https://www.sciencedaily.com/releases/2026/01/260115022808.htm>æŸ¥çœ‹åŸæ–‡</a></li></ul></div></details><h2 id=-å…³é”®è¯ç»Ÿè®¡>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2><table><thead><tr><th>å…³é”®è¯</th><th>å‡ºç°æ¬¡æ•°</th></tr></thead><tbody><tr><td>single-cell</td><td>8</td></tr><tr><td>RNA-seq</td><td>6</td></tr><tr><td>tumor</td><td>6</td></tr><tr><td>cancer</td><td>5</td></tr><tr><td>sequencing</td><td>5</td></tr><tr><td>methylation</td><td>4</td></tr><tr><td>immune</td><td>3</td></tr><tr><td>tumor microenvironment</td><td>3</td></tr><tr><td>chemokine</td><td>3</td></tr><tr><td>aging</td><td>2</td></tr><tr><td>metabolic</td><td>2</td></tr><tr><td>ChIP-seq</td><td>1</td></tr><tr><td>histone</td><td>1</td></tr><tr><td>clustering</td><td>1</td></tr><tr><td>regex:immuno(logy</td><td>therapy</td></tr><tr><td>carcinoma</td><td>1</td></tr><tr><td>T cell</td><td>1</td></tr><tr><td>ATAC-seq</td><td>1</td></tr><tr><td>genome</td><td>1</td></tr><tr><td>scRNA</td><td>1</td></tr></tbody></table><hr><h2 id=-æ›´å¤šå†…å®¹>ğŸ“ æ›´å¤šå†…å®¹</h2><details><summary><a name=æ›´å¤š-æ•°æ®å‰æ²¿></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (30æ¡)</summary><div class=details-content markdown=1><ul><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316818">GSE316818 ä¸€ç§ç»†èŒYopJå®¶æ—ä¹™é…°è½¬ç§»é…¶é€šè¿‡JAK1çš„NÎµ-ä¹™é…°åŒ–æŠ‘åˆ¶å®¿ä¸»å…ç–«ååº”</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291819">GSE291819 å•ç»†èƒ RNA è½¬å½•ç»„æ­ç¤ºäº†æ°¯æ²™å¦å‡è½»æ°®èŠ¥è¯±å¯¼çš„è§’è†œæŸä¼¤çš„æ½œåœ¨æœºåˆ¶</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316749">GSE316749 AURKA/PHB2 ä¿¡å·é€šè·¯é©±åŠ¨ KRAS G12C çªå˜å‹éå°ç»†èƒè‚ºç™Œå¯¹ KRAS G12C æŠ‘åˆ¶å‰‚äº§ç”Ÿè·å¾—æ€§è€è¯</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316223">GSE316223 Î±-çªè§¦æ ¸è›‹ç™½ä»è‚ é“æ‰©æ•£è‡³å¤§è„‘çš„ä½“å†…æ¨¡å‹</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287470">GSE287470 ç–¾ç—…ç›¸å…³å°èƒ¶è´¨ç»†èƒ TLR4-Lyn æ¿€é…¶æ˜¯ 5XFAD å°é¼ æ¨¡å‹ä¸­ç¥ç»ç‚ç—‡ã€AÎ² åå™¬ä½œç”¨ã€ç¥ç»å…ƒæŸä¼¤å’Œç»†èƒå­˜æ´»çš„å…³é”®è°ƒèŠ‚å› å­ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316754">GSE316754 è¡°è€ç»†èƒæ¸…é™¤ç–—æ³•å¢å¼ºå‰åˆ—è…ºç™ŒåŒ–ç–—çš„å…ç–«åŸæ€§</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315021">GSE315021 åˆ©ç”¨DAP-SeqæŠ€æœ¯åˆ†æè½¬å½•å› å­RGSV P3çš„å…¨åŸºå› ç»„ç»“åˆä½ç‚¹</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313496">GSE313496 å¤šç»„ç»‡ DNA ç”²åŸºåŒ–åˆ†æï¼Œæ—¨åœ¨è¯†åˆ«è„ŠæŸ±è£‚ç‰¹æœ‰çš„ç‹¬ç‰¹ç¥ç»ç»„ç»‡çš„åˆé€‚æ›¿ä»£ç»„ç»‡</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE277649">GSE277649 ç¼ºä¹ PD-1 çš„å¹²ç»†èƒæ · CD8+ T ç»†èƒé€šè¿‡é™ä½ TCR ä¿¡å·ä¼ å¯¼å’Œè‡ªæˆ‘æ›´æ–°èƒ½åŠ›æ¥é€‚åº”æ…¢æ€§åˆºæ¿€ [scRNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE277648">GSE277648 ç¼ºä¹ PD-1 çš„å¹²ç»†èƒæ · CD8+ T ç»†èƒé€šè¿‡é™ä½ TCR ä¿¡å·ä¼ å¯¼å’Œè‡ªæˆ‘æ›´æ–°èƒ½åŠ›æ¥é€‚åº”æ…¢æ€§åˆºæ¿€ [RNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310584">GSE310584 äººç±» PDA ç»†èƒç³»ï¼šç»æ›²ç¾æ›¿å°¼ (TRAM) å’Œ/æˆ–ç¾Ÿæ°¯å–¹ (HCQ) æ²»ç–—åçš„å•ç»†èƒ RNA æµ‹åº</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303670">GSE303670 æé«˜è‚¾ç§»æ¤ä¸­DSAé˜´æ€§æŠ—ä½“ä»‹å¯¼æ’æ–¥ååº”çš„ç»„ç»‡å­¦æ£€æµ‹</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302604">GSE302604 æ…¢æ€§é—´æ­‡æ€§ä½æ°§æ¨¡æ‹Ÿç¡çœ å‘¼å¸æš‚åœï¼Œé‡å¡‘è‚è„æ˜¼å¤œä»£è°¢ç»“æ„</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE292402">GSE292402 ä½¿ç”¨ KP4 PDA ç»†èƒç³»è¿›è¡Œå•ç»†èƒæ¡å½¢ç è°±ç³»è¿½è¸ª - æ›²ç¾æ›¿å°¼è¯ç‰©æ²»ç–—å‰å</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291914">GSE291914 Dnmt3aä¾èµ–çš„ä»å¤´DNAç”²åŸºåŒ–å¢å¼ºè°±ç³»å®šå‘å¹¶ç»´æŒè®°å¿†æ€§Th1å’ŒTfhç»†èƒçš„åŠŸèƒ½</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291911">GSE291911 Dnmt3a ä¾èµ–çš„ä»å¤´ DNA ç”²åŸºåŒ–å¢å¼ºè°±ç³»å®šå‘å¹¶ä¿æŒè®°å¿† Th1 å’Œ Tfh ç»†èƒçš„åŠŸèƒ½ [WGEM-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288771">GSE288771 OCI-AML3 ä¸­ LTR12C å®¶æ—çš„è¡¨è§‚é—ä¼ æ²‰é»˜</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE280160">GSE280160 ä½“å¤–é˜µåˆ— OVOL2 åœ¨ PDA ç»†èƒç³»ä¸­çš„è¿‡è¡¨è¾¾ï¼ˆæ‰¹é‡ RNA-Seqï¼‰</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE268441">GSE268441 PATU8988S PDA ç»†èƒç³»å•ç»†èƒæ¡å½¢ç è°±ç³»è¿½è¸ª</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE268229">GSE268229 KP4 PDA ç»†èƒç³»å•ç»†èƒæ¡å½¢ç è°±ç³»è¿½è¸ª</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE268077">GSE268077 HS766T PDA ç»†èƒç³»å•ç»†èƒæ¡å½¢ç è°±ç³»è¿½è¸ª</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE266034">GSE266034 äººç±»èƒ°è…ºå¯¼ç®¡è…ºç™Œç»†èƒç³»ï¼šæ­£å¸¸åŸ¹å…»åŸºä¸æ— è¡€æ¸…åŸ¹å…»åŸºä¸­çš„å•ç»†èƒRNAæµ‹åº</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE161369">GSE161369 èƒ°è…ºç™Œæ•°æ®é›†</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE161368">GSE161368 TF è¿‡è¡¨è¾¾åˆ†æåœ¨ PDA ç»†èƒç³»ä¸­ï¼ˆæ‰¹é‡ RNA-Seqï¼‰</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE160977">GSE160977 æ¥è‡ª PDAC è‚¿ç˜¤æ‚£è€…æ¥æºå¼‚ç§ç§»æ¤æ¨¡å‹çš„å•ç»†èƒæ•°æ®ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE159918">GSE159918 å…­ä¸ª PDA ç»†èƒç³»çš„æµ‹åºæ•°æ®ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316547">GSE316547 é€‰æ‹©æ€§è°ƒèŠ‚å°é¼ è‚ é“M1å’ŒM3æ¯’è•ˆç¢±å—ä½“è¡¨è¾¾å¯¹ç‰¹åŒ–ä¸Šçš®ç»†èƒå’Œä½“é‡å…·æœ‰ä¸åŒçš„å½±å“</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313846">GSE313846 Notch1èƒå†…ç»“æ„åŸŸï¼ˆNICD1ï¼‰çš„ChIPæµ‹åºåˆ†æ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308855">GSE308855 æ•´åˆå¤šç»„å­¦åˆ†ææ­ç¤ºå¾®ç¯å¢ƒé‡å¡‘æ˜¯å±‹å°˜è¨è¯±å‘è‚ºç™Œè¿›å±•çš„å…³é”®é©±åŠ¨å› ç´ </a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE223225">GSE223225 äººç±»æˆçº¤ç»´ç»†èƒè¡°è€è¿‡ç¨‹ä¸­åŠŸèƒ½æ€§é•¿é“¾éç¼–ç RNAçš„é‰´å®šå’Œè¡¨å¾</a></li></ul></div></details><hr><p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2026-01-17 21:36</em><br><em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p></div><footer class=post__footer><div class="post__tags tags clearfix"><svg class="tags__badge icon icon-tag" width="16" height="16" viewBox="0 0 32 32"><path d="M4 0h8s2 0 4 2l15 15s2 2 0 4L21 31s-2 2-4 0L2 16s-2-2-2-4V3s0-3 4-3m3 10a3 3 0 000-6 3 3 0 000 6"/></svg><ul class=tags__list><li class=tags__item><a class="tags__link btn" href=../../../tags/research/ rel=tag>Research</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/daily/ rel=tag>Daily</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/week032026/ rel=tag>Week032026</a></li></ul></div></footer></article></main><div class="authorbox clearfix"><div class=authorbox__header><span class=authorbox__name>About Bloger</span></div></div><nav class="pager flex"><div class="pager__item pager__item--prev"><a class=pager__link href=../../../posts/dailyreports/2026-01-17/ rel=prev><span class=pager__subtitle>Â«&#8201;Previous</span><p class=pager__title>ç§‘ç ”æ—¥æŠ¥ 2026-01-17</p></a></div><div class="pager__item pager__item--next"><a class=pager__link href=../../../posts/dailyreports/2026-01-19/ rel=next><span class=pager__subtitle>Next&#8201;Â»</span><p class=pager__title>ç§‘ç ”æ—¥æŠ¥ 2026-01-19</p></a></div></nav><section class=comments><div id=disqus_thread></div><script>window.disqus_config=function(){},function(){if(["localhost","127.0.0.1"].indexOf(window.location.hostname)!=-1){document.getElementById("disqus_thread").innerHTML="Disqus comments not available by default when the website is previewed locally.";return}var t=document,e=t.createElement("script");e.async=!0,e.src="//kkitown.disqus.com/embed.js",e.setAttribute("data-timestamp",+new Date),(t.head||t.body).appendChild(e)}()</script><noscript>Please enable JavaScript to view the <a href=https://disqus.com/?ref_noscript>comments powered by Disqus.</a></noscript><a href=https://disqus.com class=dsq-brlink>comments powered by <span class=logo-disqus>Disqus</span></a></section></div><aside class=sidebar><div class="widget-search widget"><form class=widget-search__form role=search method=get action=https://google.com/search><input class=widget-search__field type=search placeholder=Searchâ€¦ name=q aria-label=Searchâ€¦>
<input class=widget-search__submit type=submit value=Search>
<input type=hidden name=sitesearch value=https://ixxmu.github.io/></form></div><div class="widget-recent widget"><h4 class=widget__title>Recent Posts</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-21/>ç§‘ç ”æ—¥æŠ¥ 2026-02-21</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-20/>ç§‘ç ”æ—¥æŠ¥ 2026-02-20</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-19/>ç§‘ç ”æ—¥æŠ¥ 2026-02-19</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-18/>ç§‘ç ”æ—¥æŠ¥ 2026-02-18</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-17/>ç§‘ç ”æ—¥æŠ¥ 2026-02-17</a></li></ul></div></div><div class="widget-categories widget"><h4 class=widget__title>Categories</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../categories/dailyreport/>DailyReport</a></li><li class=widget__item><a class=widget__link href=../../../categories/learnr/>LearnR</a></li></ul></div></div><div class="widget-taglist widget"><h4 class=widget__title>Tags</h4><div class=widget__content><a class="widget-taglist__link widget__link btn" href=../../../tags/daily/ title=Daily>Daily (114)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/research/ title=Research>Research (114)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week022026/ title=Week022026>Week022026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week032026/ title=Week032026>Week032026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week042026/ title=Week042026>Week042026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week052026/ title=Week052026>Week052026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week062026/ title=Week062026>Week062026 (6)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week072026/ title=Week072026>Week072026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week082026/ title=Week082026>Week082026 (5)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week452025/ title=Week452025>Week452025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week462025/ title=Week462025>Week462025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week472025/ title=Week472025>Week472025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week482025/ title=Week482025>Week482025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week492025/ title=Week492025>Week492025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week502025/ title=Week502025>Week502025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week512025/ title=Week512025>Week512025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week522025/ title=Week522025>Week522025 (7)</a></div><a href=../../../tags/></a></div><div class="widget-social widget"><h4 class="widget-social__title widget__title">Social</h4><div class="widget-social__content widget__content"><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Facebook rel="noopener noreferrer" href=https://facebook.com/username target=_blank><svg class="widget-social__link-icon icon icon-facebook" width="24" height="24" viewBox="0 0 352 352"><path d="m0 32v288c0 17.5 14.5 32 32 32h288c17.5.0 32-14.5 32-32V32c0-17.5-14.5-32-32-32H32C14.5.0.0 14.5.0 32zm320 0v288h-83V212h41.5l6-48H237v-31c0-14 3.5-23.5 23.5-23.5h26V66c-4.4-.6-19.8-1.5-37.5-1.5-36.9.0-62 22.2-62 63.5v36h-42v48h42v108H32V32z"/></svg>
<span>Facebook</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Twitter rel="noopener noreferrer" href=https://twitter.com/username target=_blank><svg class="widget-social__link-icon icon icon-twitter" width="24" height="24" viewBox="0 0 384 312"><path d="m384 36.9c-14.1 6.3-29.3 10.5-45.2 12.4 16.3-9.7 28.8-25.2 34.6-43.6-15.2 9-32.1 15.6-50 19.1-14.4-15.2-34.9-24.8-57.5-24.8-43.5.0-78.8 35.3-78.8 78.8.0 6.2.7 12.2 2 17.9-65.5-3.3-123.5-34.6-162.4-82.3C20 26 16.1 39.6 16.1 54c0 27.3 13.9 51.4 35 65.6-12.9-.4-25.1-4-35.7-9.9v1c0 38.2 27.2 70 63.2 77.2-6.6 1.8-13.6 2.8-20.8 2.8-5.1.0-10-.5-14.8-1.4 10 31.3 39.1 54.1 73.6 54.7-27 21.1-60.9 33.7-97.8 33.7-6.4.0-12.6-.4-18.8-1.1C34.9 299 76.3 312 120.8 312c144.9.0 224.1-120 224.1-224.1.0-3.4-.1-6.8-.2-10.2 15.4-11.1 28.7-25 39.3-40.8z"/></svg>
<span>Twitter</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Instagram rel="noopener noreferrer" href=https://www.instagram.com/username target=_blank><svg class="widget-social__link-icon icon icon-instagram" width="24" height="24" viewBox="0 0 256 256"><circle cx="193" cy="59" r="15"/><path fill-rule="evenodd" d="M101 0h54c41 0 58.4 3.9 74.5 17C256.2 37.5 256 74.8 256 97.7v60c0 26.7.0 60.4-26.5 81.4-16 13.4-33.5 16.9-74.5 16.9h-54c-41 0-57.5-3.5-74.5-16.9C1 218.9.5 186.3.1 160.5L0 155V97.7c0-23-.2-60.2 26.5-80.7C45 2 60 0 101 0zm4.9 23h44.3c45.8.0 58.3 3.5 70.3 17.5 11.8 13.2 12 30.1 12.5 62.9V156c.2 20.8.3 45.8-12.5 59.5-12 14-24.5 17.5-70.3 17.5h-44.3c-45.9.0-57.3-3.5-70.4-17.5-12.2-13-12.3-36.5-12.4-56.7v-55.6c.4-32.6.7-49.6 12.4-62.7C48 26.5 60 23 105.9 23zm19.6 144.5a42 42 0 100-84 42 42 0 000 84zm0 22.5a64.5 64.5.0 100-129 64.5 64.5.0 000 129z"/></svg>
<span>Instagram</span></a></div></div></div></aside></div><footer class=footer><div class="container footer__container flex"><div class=footer__copyright>&copy; 2026 ç”Ÿä¿¡æ™®æ‹‰æ–¯.
<span class=footer__copyright-credits>Generated with <a href=https://gohugo.io/ rel="nofollow noopener" target=_blank>Hugo</a> and <a href=https://github.com/Vimux/Mainroad/ rel="nofollow noopener" target=_blank>Mainroad</a> theme.</span></div></div></footer></div><script async defer src=../../../js/menu.js></script><script src=../../../js/custom.js></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.6/MathJax.js?config=TeX-AMS-MML_HTMLorMML" async></script></body></html>